RTS Sample Clauses

RTS. The term “RTS” shall mean Radiation Therapy Services, Inc., a Florida corporation.
AutoNDA by SimpleDocs
RTS. The Term “RTS” means 21st Century Oncology Holdings, Inc.
RTS. RTT Lxx Xxxxxxxx Tennessee Medicaid (000) 000-0000 Dept. of Health-Medicaid On Formulary? No No No No No No No No 700 Xxxxxx Xxxxxx, 0xx Xxxxx If yes, AWP - ?%: Nxxxxxxxx, XX 00000 Dispensing Fee: 640 Note: (Must contract with Tenn Care) Other Contacts Jxxx Xxxxxxxx (000)000-0000 Medicaid Survey 05/2000 HCT HSR HLiq HPD HHC DTC RTS RTT Kxxxx Xxxxxx, RPh, MS Kansas Department SRS (000) 000-0000 Blue Cross Blue Shield KS On Formulary? Y No Y Y Y Y Y Health Care If yes, AWP - ?%: Room 651-S DSOB Dispensing Fee: 900 XX Xxxxxxxx Topeka, KS 66612-1570 981 Other Contacts Kxxxxxx Sxxxxx (000) 000-0000 HCT HSR HLiq HPD HHC DTC RTS RTT M.X. Xxxxxxxxxx (000) 000-0000 Lousiana Dept. of Health & Hospital On Formulary? Y X X X X X X X X.X. Xxx 00000 If yes, AWP - ?%: Bxxxx Xxxxx, XX 00000 Dispensing Fee: Note: Anti-Tussives not covered Other Contacts Sxxxx Xxxxxx (000) 000-0000 HCT HSR HLiq HPD HHC DTC RTS RTT Txx Xxxxxxxx Oklahoma Health Care Authority (000) 000-0000 Lincoln Plaza On Formulary? Y X X X X X 0000 X. Xxxxxxx Blvd. lf yes, AWP-?%: Oxxxxxxx Xxxx, XX 00000-0000 640 Dispensing Fee: Other Contacts Axxx Xxxxx (000) 000-0000 Jxxx Xxxxxx (000) 000-0000 HCT HSR HLiq HPD HHC DTC RTS RTT Hxxxxxx Xxxxxx (000) 000-0000 Texas Dept. of Health On Formulary? Yes Yes Yes Yes Yes Yes Yes Vendor Drug Rebates If yes, AWP-?%: 10000 Xxxxx Xxxxx Xxxxxx Dispensing Fee: Axxxxx, XX 00000 (covered under the state 640 with the drug vendor program) Other Contacts Pxxxxxxx Xxxxxxx (000) 000-0000 Sxxxxx Xxxxxx (000) 000-0000 Medicaid Survey 05/2000 HCT HSR HLiq HPD HHC DTC RTS RTT Dxxxxxx Xxxxx NC Division of Medical Assistance (000) 000-0000 Electronic Data Systems On Formulary? Yes Yes Yes Yes Yes Yes Yes Yes 4000 Xxxxxx Xxxx Xxxxx If yes, AWP - ?%: Rxxxxxx, XX 00000 Dispensing Fee: 980 Other Contacts Axxx Xxxxxxx (000) 000-0000 Sxxxxx Xxxxxxx, RPh (000) 000-0000 Bxxxx Xxxxxx (000) 000-0000 HCT HSR HLiq HPD HHC DTC RTS RTT Vxxxx Pletschker (000) 000-0000 SC Dept. of Health & Human Serv. On Formulary? Yes Yes Yes Yes Yes Yes Yes Yes 1000 Xxxx Xxxxxx If yes, AWP - ?% P.X. Xxx 0000 Dispensing Fee: Cxxxxxxx, XX 00000-0000 (covered under Select Health 640 and First Choice with the State) Other Contacts Bxxxx Xxxxxx (000) 000-0000 Kxxxx Xxxx (000) 000-0000 Jxxxx X. Xxxxx (000) 000-0000 HCT HSR HLiq HPD HHC DTC RTS RTT Sxxxx Xxxxxxxx Agency for Health Care Admin. (000) 000-0000 Pharmacy Services Section On Formulary? Yes Yes Yes Yes Yes Yes Bxxx 0, Xxxx 000 If yes, AWP - ?%: 43.65 64.82 40.3...
RTS. Buyer’s Initials The waivers and releases by Buyer herein contained shall survive the Close of Escrow and the recordation of the Grant Deed and will not be deemed merged into the Grant Deed upon its recordation.
RTS and the Fund may amend, modify or supplement this Agreement only by a written instrument executed by both RTS and the Fund. If any such amendment, modification, or supplement causes an increase or decrease in the price of, or time required for, the performance of this Agreement, an equitable adjustment shall be made, and this adjustment shall be mutually agreed upon by RTS and the Fund and the Agreement modified in writing accordingly.
RTS. The term “RTS” shall mean RTS Packaging, LLC and any successor to RTS Packaging, LLC.
RTS. Ltd. [1949] 1 All E.R. 465 and Kitchen v. R.A.F. Association and others [1958] 3 All E.R. 241 in which meaning of the word “fraud” as used in s. 26 of the Limitation Act 1939, of which the Guyana counterpart is s. 21 of the Title to Land (Prescription and Limitation) Ordinance, Cap. 184, was consid- ered. In the latter case Lord EVERSHED, M.R. said at p. 249;– “It is now clear, however, that the word ‘fraud’ in section 26(b) of the Limitation Act 1939 is by no means limited to common law fraud or deceit. Equally it is clear having regard to the decision in Xxxxxx v.
AutoNDA by SimpleDocs
RTS. The following rules apply to any games which are categorized as being of a RTS (Real Time Strategy) genre. These include, but are not limited to Starcraft 2 and Warcraft. In cases where rules specific to any game which is also generally considered as forming part of the same genre are separately listed, these will complement, and supersede (if applicable), the genre-specific rules. The Operator reserves the right to apply the settlement rules of this genre to any games not listed above which are generally acknowledged as such.

Related to RTS

  • Subsidiaries and Partnerships Borrower has no subsidiaries and is not a party to any partnership agreement or joint venture agreement.

  • Capitalization; Subsidiaries (a) As of the close of business on May 6, 2022 (the “Capitalization Date”), the Company was authorized to issue a maximum of (i) 200,000,000 Common Shares, 71,043,181 of which were issued and outstanding and none of which were held by the Company as treasury shares, (ii) 3,992 shares of series A preferred shares, no par value (“Series A Preferred Shares”), 1,715 of which were issued and outstanding, and (iii) 3,992 shares of series B preferred shares, no par value (“Series B Preferred Shares”), 1,697 of which were issued and outstanding, and (iv) 9,992,016 shares of unclassified preferred shares of the Company, no par value per share (“Unclassified Preferred Shares” and, together with the Series A Preferred Shares and the Series B Preferred Shares, the “Company Preferred Shares”), no shares of which were issued and outstanding. There are no other classes of shares of the Company and no bonds, debentures, notes or other Indebtedness or securities of the Company having the right to vote (or convertible into or exercisable for securities having the right to vote) on any matters on which holders of any class of shares of the Company may vote authorized, issued or outstanding. As of the close of business on the Capitalization Date, there were (A) outstanding Company Options to purchase 8,379,746 Common Shares, (B) 2,032,586 outstanding Company RSUs, including 40,000 outstanding Company PRSUs (assuming target performance) and 25,500 Company RSUs that have been deferred under the Company’s 2022 deferral election agreements, (C) rights to purchase a maximum of 2,657,085 Common Shares pursuant to the Company ESPP were outstanding (determined based on the fair market value of a Common Share on the first day of the current offering period) and (D) 1,711,774 Common Shares reserved for future issuance under the Company Share Plans. Since the close of business on the Capitalization Date, and except as disclosed on Section 3.2(a) of the Company Disclosure Letter, there has been no issuance or grant of any Common Shares, Company Preferred Shares or any other securities of the Company, other than any de minimis issuances of Common Shares or other securities in accordance with the exercise, vesting or settlement, as applicable, of any Company Share Plan Awards outstanding as of the close of business on the Capitalization Date in accordance with the Company Share Plan Awards and disclosed on Section 3.2(a) of the Company Disclosure Letter.

  • Affiliates and Subsidiaries Borrower's affiliates and subsidiaries (those entities in which Borrower has either a controlling interest or at least a 25% ownership interest) and their addresses, and the names of Borrower's principal shareholders, are as provided on a schedule delivered to Bank on or before the date of this Agreement.

  • Officers of the Surviving Corporation The officers of the Company immediately prior to the Effective Time shall be the initial officers of the Surviving Corporation, each to hold office until the earlier of their resignation or removal or until their respective successors are duly elected and qualified, as the case may be.

  • Company Predecessor and Subsidiaries The Company makes each of the representations contained in Sections 5(a), (b), (c), (d), (e), (f), (h), (j), (k), (l), (o), (p), (r), (s) and (t) of this Agreement, as same relate or could be applicable to each Subsidiary. All representations made by or relating to the Company of a historical or prospective nature and all undertakings described in Section 9 shall relate, apply and refer to the Company and Subsidiaries and their predecessors and successors.

  • Ownership by the Company If, during Executive’s employment by the Company, Executive creates any work of authorship fixed in any tangible medium of expression that is the subject matter of copyright (such as videotapes, written presentations, or acquisitions, computer programs, E-mail, voice mail, electronic databases, drawings, maps, architectural renditions, models, manuals, brochures, or the like) relating to the Company’s business, products, or services, whether such work is created solely by Executive or jointly with others (whether during business hours or otherwise and whether on the Company’s premises or otherwise), including any Work Product, the Company shall be deemed the author of such work if the work is prepared by Executive in the scope of Executive’s employment; or, if the work relating to the Company’s business, products, or services is not prepared by Executive within the scope of Executive’s employment but is specially ordered by the Company as a contribution to a collective work, as a part of a motion picture or other audiovisual work, as a translation, as a supplementary work, as a compilation, or as an instructional text, then the work shall be considered to be work made for hire and the Company shall be the author of the work. If the work relating to the Company’s business, products, or services is neither prepared by Executive within the scope of Executive’s employment nor a work specially ordered that is deemed to be a work made for hire during Executive’s employment by the Company, then Executive hereby agrees to assign, and by these presents does assign, to the Company all of Executive’s worldwide right, title, and interest in and to such work and all rights of copyright therein.

  • Directors and Officers of the Surviving Corporation The directors and officers of Merger Sub immediately prior to the Effective Time shall serve as the initial directors and officers of the Surviving Corporation, until their respective successors are duly elected or appointed and qualified.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!